Hypha Labs delays FY 2025 annual report filing

Hypha Labs, Inc. filed a Form 12b-25 to notify regulators that its Form 10-K for the fiscal year ended September 30, 2025 will be filed late.

Rhea-AI Filing Summary

Hypha Labs, Inc. filed a Form 12b-25 to notify regulators that its Form 10-K for the fiscal year ended September 30, 2025 will be filed late. The company explains that it could not submit the annual report on time because the audit of its financial statements for that fiscal year had not been completed by the close of business on December 29, 2025, the prescribed due date. By filing this notification of late filing, Hypha Labs formally discloses the delay in its audited annual financial report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Hypha Labs, Inc. (FUNI) announce in this NT 10-K filing?

Hypha Labs, Inc. filed a Form 12b-25, which is a notification that its Form 10-K annual report for the fiscal year ended September 30, 2025 will be filed late.

Which reporting period is affected by Hypha Labs, Inc.'s delayed filing?

The delay affects Hypha Labs, Inc.'s Form 10-K for its fiscal year ended September 30, 2025.

Why is Hypha Labs, Inc. filing its 2025 annual report late?

The company states that the Form 10-K could not be filed within the prescribed time period because the audit of its financial statements for the fiscal year ended September 30, 2025 had not been completed by the close of business on December 29, 2025.

What SEC rule does Hypha Labs, Inc. reference for the late 10-K filing?

The company uses Form 12b-25, which references Rule 12b-25 and allows a registrant to notify the SEC when a required report cannot be filed on time without unreasonable effort or expense.

Who signed the Hypha Labs, Inc. notification of late filing?

The notification was signed on behalf of Hypha Labs, Inc. by A. Stone Douglass, who is identified as the Principal Financial Officer.

Where is Hypha Labs, Inc.'s principal executive office located?

The principal executive office of Hypha Labs, Inc. is located at 5940 S. Rainbow Boulevard, Las Vegas, NV 89118.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/30/2025 - 04:23 PM EST Learn about SEC filing dates

	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	SEC FILE NUMBER 000-54239
		CUSIP NUMBER 253825202
	FORM 12b-25
	NOTIFICATION OF LATE FILING

(Check one):	☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR
	For Period Ended: September 30, 2025

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the ltem(s) to which the notification relates:

PART 1- REGISTRANT INFORMATION

HYPHA LABS, INC.

Full Name of Registrant

Former Name if Applicable

5940 S. Rainbow Boulevard

Address of Principal Executive Office {Street and Number)

Las Vegas, NV 89118

City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule I 2b-25(b), the following should be completed. (Check box if appropriate)

☒	(a)	The reasons described in reasonable detail in Part Ill of this form could not be eliminated without unreasonable effort or expense;
	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,1 l-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule I 2b-25(c) has been attached if applicable.

PART III -NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report portion thereof, could not be filed within the prescribed time period.

The Registrant’s Form 10-K for its fiscal year ended September 30, 2025 could not be filed within the prescribed time period without unreasonable effort or expense because the audit of the Registrant’s financial statements for the fiscal year ended September 30, 2025 had not been completed prior to the close of business on December 29, 2025.

SEC 1344 (04-09)	Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid 0MB control number.
	(Attach extra Sheets if Needed)

PART IV - OTHER INFORMATION

(I) Name and telephone number of person to contact in regard to this notification

A. Stone Douglass		(858)		583-1017
(Name)		(Area Code)		(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or l5(d) of the Securities Exchange Act of 1934 or Section 30 of the investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
	Yes ☒ No ☐
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	Yes ☐ No ☒
	If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

HYPHA LABS, INC.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 30, 2025	By	/s/ A. Stone Douglass
		A. Stone Douglass, Principal Financial Officer